Updated:
VirTrial
VirTrial is a telemedicine company offering a virtual care management platform for the clinical trial industry. The platform integrates video, text, and...
Overview
VirTrial is a telemedicine company offering a virtual care management platform for the clinical trial industry. The platform integrates video, text, and email capabilities to facilitate Decentralized Clinical Trials. VirTrial was acquired by Signant Health on November 30, 2020.
General information
Firm type
RIA
Year founded
2010
Location
Region
North America
Country
United States
City
Scottsdale
Corporate office
Scottsdale, AZ, United States
Sector focus
Frequently asked questions
Who runs investment decisions at VirTrial?
VirTrial's executive team is not publicly disclosed on its website or in standard business registries. The firm's leadership structure remains opaque, with no named CEO, CIO, or managing partners listed publicly as of early 2026.
How does VirTrial source proprietary deal flow?
VirTrial does not appear to operate as an investment firm with proprietary deal flow. It is a technology company that develops and sells clinical trial software to research sites, sponsors, and CROs. No investment activity or fund structures have been identified.
Which sectors does VirTrial explicitly avoid?
VirTrial does not publish an investment mandate or sector-exclusion list. As a software provider, its focus is limited to clinical trial operations within healthcare and life sciences.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research VirTrial in Altss
Explore available research and relationship coverage for this adviser in Altss.